Clinical Trial Update: Endometriosis Trial: Study of NBI-56418 in Endometriosis [Phase 2]

View source ↗

Summary

Abbott's Phase 2 trial of NBI-56418 for endometriosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometriosis

Drugs mentioned

• NBI-56418

Snippet

Sponsor: Abbott | Conditions: Endometriosis | Phase 2 | Status: COMPLETED